Ruth Webster from the George Institute in Sydney, Australia, discusses the potential of polypills to prevent atherosclerosis as part of a wider plan to meet non-communicable disease targets by 2025.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
